Biolife Solutions (BLFS) Non Operating Investment Income (2014 - 2024)
Biolife Solutions (BLFS) reported Non Operating Investment Income of -$4.1 million for Q2 2024, down 891.24% quarter-over-quarter from -$411000.0 in Q1 2023.
Biolife Solutions (BLFS) Non Operating Investment Income (2014 - 2024) Analysis & Trends
Biolife Solutions (BLFS) has 6 years of Non Operating Investment Income data on file, last reported at -$4.1 million in Q2 2024.
- Non Operating Investment Income for Q2 2024 came in at -$4.1 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was -$4.1 million (changed 0.0% YoY), and the FY2024 annual result was -$4.1 million, changed N/A from the prior year.
- Non Operating Investment Income fell to -$4.1 million in Q2 2024 per BLFS's latest filing, from -$411000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $1.1 million in Q3 2020 and troughed at -$4.1 million in Q2 2024.
- A 4-year average of -$442166.7 and a median of $12500.0 in 2020 frame the typical range for Non Operating Investment Income.
- On a YoY basis, Non Operating Investment Income climbed as much as 123.37% in 2023 and fell as far as 123.37% in 2023.
- A 4-year view of Non Operating Investment Income shows it stood at $209000.0 in 2020, then jumped by 233.49% to $697000.0 in 2022, then sank by 158.97% to -$411000.0 in 2023, then plunged by 891.24% to -$4.1 million in 2024.
- Business Quant data shows BLFS's Non Operating Investment Income at -$4.1 million in Q2 2024, -$411000.0 in Q1 2023, and $697000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Biolife Solutions | 1.27 Bn | 1.19 Bn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -4.07 Mn |
| Jun 30, 2024 | -4.07 Mn |
| Mar 31, 2023 | -411,000.00 |
| Mar 31, 2023 | -411,000.00 |
| Sep 30, 2022 | 697,000.00 |
| Sep 30, 2022 | 697,000.00 |
| Mar 31, 2022 | -184,000.00 |
| Mar 31, 2022 | -184,000.00 |
| Dec 31, 2020 | 209,000.00 |
| Dec 31, 2020 | 209,000.00 |
| Sep 30, 2020 | 1.11 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2015 | -441.00 |
| Jun 30, 2015 | -441.00 |
| Dec 31, 2014 | 158.00 |
| Dec 31, 2014 | 158.00 |
| Sep 30, 2014 | -3,099.00 |
| Sep 30, 2014 | -3,099.00 |
| Jun 30, 2014 | -3,507.00 |
| Jun 30, 2014 | -3,507.00 |